ACTU · Actuate Therapeutics, Inc.
$1.27
+0.04 (+3.25%)
At close · Aug 21
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the above matters, we have concluded that there is substantial doubt regarding the Company’s ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$30.50M
Shares
24.01M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$22.23M
+18.5%
FY2025
Diluted EPS
-$1.06
+67.5%
FY2025
Operating Cash Flow
-$19.21M
+12.1%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| $8.94M | $10.29M | $18.68M | $21.71M | |
| $11.83M | $12.2M | $6.48M | $3.27M | |
| $20.77M | $22.5M | $25.16M | $24.97M | |
| -$20.77M | -$22.5M | -$25.16M | -$24.97M | |
| $20.25K | $20.25K | $18.72K | $43.64K | |
| $339.84K | $287.71K | $222.29K | $352.67K | |
| $319.59K | $267.46K | -$2.12M | $229.21K | |
| — | $800 | $800 | $0 | |
| -$20.45M | -$22.23M | -$27.29M | -$24.74M | |
| USD/shares | — | -$1.06 | -$3.26 | -$17.24 |
| USD/shares | — | -$1.06 | -$3.26 | -$17.24 |
| shares | — | 21.02M | 8.37M | 1.43M |
| shares | — | 21.02M | 8.37M | 1.43M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 2.88×
EV/EBIT
—
P/E (TTM)
—
Peer median 5.92×
Peer medians compare against the 268 similar-size Biotechnology companies (of 546 listed).
Key facts
CIK
1652935
CUSIP
005083100
13F (30d)
52 filings
52 filers
Visit website
Investor relations